Rheumatology
medac itself is involved in autoimmune disease research as well as in the development of drugs and diagnostics in this area and promotes public research. Our aim is to continuously generate new findings that have a positive impact on everyday clinical practice and the daily lives of patients. Beyond this, medac also encourages scientific exchange by organising global symposia on autoimmune diseases, to provide further training for specialists and to raise awareness. In doing so, we are working closely together with our broad network of authorities, key opinion leaders, academia and other relevant players.
Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to medac Pharma at info@medacpharma.co.uk.
We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).